CoChat

Megestrol Acetate Stimulates Weight Gain and Ventilation in Underweight COPD Patients

Weisberg, Jeffrey, Wanger, Jack, Olson, Jeffery, Streit, Barry, Fogarty, Charles, Martin, Thomas, Casaburi, Richard · 2002 · Chest
Cited by 81

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1378/chest.121.4.1070

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 42

  1. American Thoracic Society, 1995, Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 152, S77
  2. Donahoe, 1990, Nutritional assessment and support in chronic obstructive pulmonary disease, Clin Chest Med, 11, 487, 10.1016/S0272-5231(21)00713-9 · DOI
  3. Woeters, 2000, Nutrition and metabolism in COPD, Chest, 117, 274S, 10.1378/chest.117.5_suppl_1.274S · DOI
  4. Schols, 2000, Nutrition in chronic obstructive pulmonary disease, Curr Opin Pulm Med, 6, 110, 10.1097/00063198-200003000-00005 · DOI · Paper page
  5. Schols, 1993, Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation, Am Rev Respir Dis, 147, 1151, 10.1164/ajrccm/147.5.1151 · DOI · Paper page
  6. Thurlbeck, 1978, Diaphragm and body weight in emphysema, Thorax, 33, 483, 10.1136/thx.33.4.483 · DOI · Paper page
  7. Wilson, 1989, Body weight in chronic obstructive pulmonary disease: the National Institutes of Health intermittent positive pressure breathing trial, Am Rev Respir Dis, 139, 1435, 10.1164/ajrccm/139.6.1435 · DOI · Paper page
  8. Donahoe, 1997, Nutritional support in advanced lung disease: a pulmonary cachexia syndrome, Clin Chest Med, 18, 547, 10.1016/S0272-5231(05)70401-9 · DOI
  9. Schols, 1998, Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease, Am J Respir Crit Care Med, 157, 1791, 10.1164/ajrccm.157.6.9705017 · DOI · Paper page
  10. Lai, 1994, Management of anorexic patients in radiotherapy: a prospective randomized comparison of megestrol acetate and prednisolone, J Pain Symptom Manage, 9, 265, 10.1016/0885-3924(94)90104-X · doi:10.1016/0885-3924(94)90104-x
  11. Osoba, 1994, Phase II trial of megestrol in the supportive care of patients receiving dose-intensive chemotherapy, Oncology, 8, 43
  12. Von Roenn, 1994, Randomized trials of megestrol acetate for AIDS-associated anorexia and cachexia, Oncology, 51, 19, 10.1159/000227411 · doi:10.1159/000227411
  13. Sutton, 1975, Progesterone for outpatient treatment of Pickwickian syndrome, Ann Intern Med, 83, 476, 10.7326/0003-4819-83-4-476 · DOI · Paper page
  14. Milerad, 1985, Alveolar hypoventilation treated with medroxyprogesterone, Arch Dis Child, 60, 150, 10.1136/adc.60.2.150 · DOI
  15. Dolly, 1983, Medroxyprogesterone acetate and COPD: effect on breathing and oxygenation in sleeping and awake patients, Chest, 84, 394, 10.1378/chest.84.4.394 · doi:10.1378/chest.84.4.394
  16. Tatsumi, 1986, Effect of chlormadinone acetate on ventilatory control in patients with chronic obstructive pulmonary disease, Am Rev Respir Dis, 133, 552
  17. Vos, 1994, Effects of chlormadinone acetate, acetazolamide and oxygen on awake and asleep gas exchange in patients with chronic obstructive pulmonary disease, Eur Respir J, 7, 850, 10.1183/09031936.94.07050850 · doi:10.1183/09031936.94.07050850
  18. Tatsumi, 1987, Effect of chlormadinone acetate on sleep arterial oxygen desaturation in patients with chronic obstructive pulmonary disease, Chest, 91, 688, 10.1378/chest.91.5.688 · doi:10.1378/chest.91.5.688
  19. American Thoracic Society, 1995, Standardization of spirometry, 1994 update, Am J Respir Crit Care Med, 152, 1107, 10.1164/ajrccm.152.3.7663792 · DOI · Paper page
  20. Crapo, 1981, Reference spirometric values using techniques and equipment that meet ATS recommendations, Am Rev Respir Dis, 123, 659
  21. Ellis, 2000, Human body composition: in vivo methods, Physiol Rev, 80, 649, 10.1152/physrev.2000.80.2.649 · DOI · Paper page
  22. Steel, 1996, Timed walking tests of exercise capacity in chronic cardiopulmonary illness, J Cardiopulm Rehabil, 16, 25, 10.1097/00008483-199601000-00003 · DOI · Paper page
  23. Guyatt, 1985, How should we measure function in patients with chronic heart and lung disease?, J Chron Dis, 38, 517, 10.1016/0021-9681(85)90035-9 · DOI · Paper page
  24. Mahler, 1984, The measurement of dyspnea: contents, interobserver agreement, and physiologic correlates of two new clinical indexes, Chest, 85, 751, 10.1378/chest.85.6.751 · DOI · Paper page
  25. Oster, 1994, Megestrol acetate in patients with AIDS and cachexia, Ann Intern Med, 121, 400, 10.7326/0003-4819-121-6-199409150-00002 · DOI
  26. Weisberg, 2000, Effects of megestrol acetate (MA) in patients with weight loss associated with chronic obstructive pulmonary disease (COPD): a pilot study [abstract], J Am Pharm Assoc, 40, 294
  27. Schols, 2000, Nutritional abnormalities and supplementation in chronic obstructive pulmonary disease, Clin Chest Med, 21, 753, 10.1016/S0272-5231(05)70182-9 · DOI
  28. American Thoracic Society/European Respiratory Society statement, 1999, Skeletal muscle dysfunction in chronic obstructive lung disease, Am J Respir Crit Care Med, 159, S1
  29. Schols, 1995, Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease: a placebo-controlled randomized trial, Am J Respir Crit Care Med, 152, 1268, 10.1164/ajrccm.152.4.7551381 · DOI · Paper page
  30. Burdet, 1997, Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease: a prospective, randomized, controlled study, Am J Respir Crit Care Med, 156, 1800, 10.1164/ajrccm.156.6.9704142 · DOI · Paper page
  31. Ferreira, 1998, The influence of 6 months of oral anabolic steroids on body mass and respiratory muscles in undernourished COPD patients, Chest, 114, 19, 10.1378/chest.114.1.19 · DOI · Paper page
  32. Loprinzi, 1993, Body composition changes in patients who gain weight while receiving megestrol acetate, J Clin Oncol, 11, 152, 10.1200/JCO.1993.11.1.152 · DOI · Paper page
  33. Casaburi, 1998, Pharmacologic modulators of respiratory control, Monaldi Arch Chest Dis, 53, 287
  34. Altose, 1986, The pharmacology of respiratory depressants and stimulants, Clin Chest Med, 7, 481, 10.1016/S0272-5231(21)01117-5 · DOI
  35. Bayliss, 1992, Central nervous mechanisms of progesterone action: application to the respiratory system, J Appl Physiol, 73, 393, 10.1152/jappl.1992.73.2.393 · DOI · Paper page
  36. Leinung, 1995, Induction of adrenal suppression by megestrol acetate in patients with AIDS, Ann Intern Med, 122, 843, 10.7326/0003-4819-122-11-199506010-00006 · DOI
  37. Stockbein, 1999, Adrenal suppression in children with the human immunodeficiency virus treated with megestrol acetate, J Pediatr, 134, 368, 10.1016/S0022-3476(99)70467-1 · doi:10.1016/s0022-3476(99)70467-1
  38. Subramanian, 1997, Clinical adrenal insufficiency in patients receiving megestrol acetate, Arch Intern Med, 157, 1008, 10.1001/archinte.1997.00440300118010 · doi:10.1001/archinte.1997.00440300118010 · Paper page
  39. Loprinzi, 1990, Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia, J Natl Cancer Inst, 82, 1127, 10.1093/jnci/82.13.1127 · DOI · Paper page
  40. Bhasin, 1997, Replacement doses of testosterone increase fat-free mass and muscle size in hypogonadal men, J Clin Endocrinol Metab, 82, 407
  41. Alexieva-Figusch, 1984, Treatment of metastatic breast cancer patients with different dosages of megestrol acetate; dose relations, metabolic and endocrine effects, Eur J Cancer Oncol, 20, 33, 10.1016/0277-5379(84)90031-2 · DOI
  42. Henry, 1992, Diabetes mellitus induced by megestrol acetate in a patient with AIDS and cachexia, Ann Intern Med, 116, 53, 10.7326/0003-4819-116-1-53 · DOI

Cited by

Metadata

Authors
Weisberg, J., Wanger, J., Olson, J., Streit, B., Fogarty, C., Martin, T., & Casaburi, R.
Venue
Chest
Publisher
Elsevier BV
Published
2002-04
Volume
121
Issue
4
Pages
1070-1078
ISSN
0012-3692
Cited by
81
References
3
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.